Pharmaceutical Maker Pays $7.9 Million over Alleged Claims for Medicare to Pay for OTC Drugs
Pharmaceutical company Akorn Operating Company LLC has agreed to pay $7.9 million to settle allegations that its handling of medications it produced led to fraudulent claims to Medicare.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.